De Boer NKH, Peyrin-Biroulet L, Jharap B, Sanderson JD, Meijer B, Atreya I, Barclay ML, Colombel JF, Lopez A, Beaugerie L, Marinaki AM, Van Bodegraven AA, Neurath M (2018)
Publication Type: Journal article
Publication year: 2018
Book Volume: 12
Pages Range: 610-620
Journal Issue: 5
Thiopurines, available as azathioprine, mercaptopurine, and thioguanine, are immunomodulating agents primarily used to maintain corticosteroid-free remission in patients with inflammatory bowel disease. To provide a state-of-the-art overview of thiopurine treatment in inflammatory bowel disease, this clinical review critically summarises the available literature, as assessed by several experts in the field of thiopurine treatment and research in inflammatory bowel disease.
APA:
De Boer, N.K.H., Peyrin-Biroulet, L., Jharap, B., Sanderson, J.D., Meijer, B., Atreya, I.,... Neurath, M. (2018). Thiopurines in Inflammatory Bowel Disease: New Findings and Perspectives. Journal of Crohns & Colitis, 12(5), 610-620. https://doi.org/10.1093/ecco-jcc/jjx181
MLA:
De Boer, Nanne K. H., et al. "Thiopurines in Inflammatory Bowel Disease: New Findings and Perspectives." Journal of Crohns & Colitis 12.5 (2018): 610-620.
BibTeX: Download